Roots Analysis has done a detailed study on Pharmaceutical Polymers / Medical Polymers Market, 2023 – 2035, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
Key Market Insights
§ Currently, over 145 companies claim to manufacture various natural, semi-synthetic and synthetic pharmaceutical polymers; around 15% players develop more than three pharmaceutical polymer compositions
§ 75% of the players claim to have the necessary expertise to produce thermoplastics; firms are primarily offering polymers for use in excipients, drug delivery and packaging
§ The current market landscape is highly fragmented, featuring the presence of both new entrants and established players across key geographical regions
§ In pursuit of obtaining a competitive edge, industry stakeholders are actively upgrading their existing capabilities and adding new competencies to enhance their respective product portfolios
§ The number of partnerships inked in this domain demonstrates the growing interest of industry stakeholders; ~30% of the deals were inked for product development
§ DELT analysis focuses on monitoring the internal and external forces that may affect the strategic business of a company; further, it provides a consolidated view on the likely threats and opportunities within this domain
§ The pharmaceutical polymers / medical polymers market is likely to grow at a steady pace, till 2035; the projected opportunity is anticipated to be well distributed across types of polymers, area of applications and key regions
Table of Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Polymers
3.3. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Pharmaceutical Polymer / Medical Polymer Manufacturers: Overall Market Landscape
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Pharmaceutical Polymer / Medical Polymer Manufacturers: Company Competitiveness Analysis
5.4.1. Company Competitiveness Analysis: Players based in North America
5.4.2. Company Competitiveness Analysis: Players based in Europe
5.4.3. Company Competitiveness Analysis: Players based in Asia-Pacific and Rest of the World
6. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN NORTH AMERICA
6.1. Chapter Overview
6.2. Americhem
6.2.1. Company Overview
6.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Celanese
6.3.1. Company Overview
6.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Eastman
6.5. Lubrizol Life Science
6.6. LyondellBasell
7. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN EUROPE
7.1. Chapter Overview
7.2. Borealis
7.2.1. Company Overview
7.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Henkel
7.4. KRAIBURG TPE
7.5. SEQENS
7.6. Solvay
8. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN ASIA-PACIFIC AND REST OF THE WORLD
8.1. Chapter Overview
8.2. Corel Pharma Chem
8.2.1. Company Overview
8.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. Kuraray
8.4. Phon Tech
8.5. Sumitomo Chemical
8.6. Zylog ElastoComp
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Pharmaceutical Polymers / Medical Polymers: List of Partnerships and Collaborations
10. PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS: DELT ANALYSIS
10.1. Chapter Overview
10.2. Key Parameters
10.3. Methodology
10.4. DELT Analysis: Pharmaceutical Polymer / Medical Polymer Manufacturers
10.5. Concluding Remarks
11. CASE STUDY: RECENT TRENDS RELATED TO PHARMACEUTICAL / MEDICAL POLYMERS
11.1 Chapter Overview
11.2 Recent Trends Related to Pharmaceutical / Medical Polymers
11.3. Concluding Remarks
12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Forecast Methodology
12.3. Pharmaceutical Polymers / Medical Polymers Market, 2023-2035
13. CONCLUDING REMARKS
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Cassion Biotech
14.3. Celares
14.4. Daikyo Seiko
15. APPENDIX 1: TABULATED DATA
16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/medical-polymers-market.html
You may also be interested in the following titles:
| Decentralized Clinical Trials / Virtual Clinical Trials Market |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek